Cheng WY - Search Results

1

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population.

Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Mahendran M, Lejeune D, Yu LH, Duh MS. Cheng WY, et al. Adv Ther. 2021 Aug;38(8):4461-4479. doi: 10.1007/s12325-021-01825-4. Epub 2021 Jul 17. Adv Ther. 2021. PMID: 34275086 Free PMC article.

2

Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy.

Vekeman F, Cheng WY, Sasane M, Huynh L, Duh MS, Paley C, Mesa RA. Vekeman F, et al. Among authors: cheng wy. Leuk Lymphoma. 2015;56(10):2803-11. doi: 10.3109/10428194.2015.1016933. Epub 2015 Mar 30. Leuk Lymphoma. 2015. PMID: 25676036

3

Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma.

Kumar SK, Ma E, Engebretson AE, Buadi FK, Lacy MQ, Dispenzieri A, Duh MS, Lafeuille MH, Lefebvre P, Cheng WY, Dea K, Rembert D, Patt D, Niculescu L, Quick M, Rajkumar SV. Kumar SK, et al. Among authors: cheng wy. Leukemia. 2016 Apr;30(4):995-8. doi: 10.1038/leu.2015.225. Epub 2015 Aug 14. Leukemia. 2016. PMID: 26271606 No abstract available.

4

Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.

Vekeman F, Sasane M, Cheng WY, Ramanakumar AV, Fortier J, Qiu Y, Duh MS, Paley C, Adams-Graves P. Vekeman F, et al. Among authors: cheng wy. J Med Econ. 2016;19(3):292-303. doi: 10.3111/13696998.2015.1117979. Epub 2015 Nov 30. J Med Econ. 2016. PMID: 26618853 Free article.

5

Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database.

Quinlan SC, Cheng WY, Ishihara L, Irizarry MC, Holick CN, Duh MS. Quinlan SC, et al. Among authors: cheng wy. Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):413-21. doi: 10.1002/pds.3975. Epub 2016 Feb 17. Pharmacoepidemiol Drug Saf. 2016. PMID: 26889887

6

Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome.

Piña-Garza JE, Montouris GD, Vekeman F, Cheng WY, Tuttle E, Giguere-Duval P, Duh MS, Shen V, Saurer TB, Isojarvi J. Piña-Garza JE, et al. Among authors: cheng wy. Epilepsy Behav. 2017 Aug;73:46-50. doi: 10.1016/j.yebeh.2017.05.021. Epub 2017 Jun 10. Epilepsy Behav. 2017. PMID: 28609734 Free article.

7

Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting.

Oh WK, Miao R, Vekeman F, Sung J, Cheng WY, Gauthier-Loiselle M, Dhawan R, Duh MS. Oh WK, et al. Among authors: cheng wy. Clin Genitourin Cancer. 2017 Jun 19:S1558-7673(17)30170-2. doi: 10.1016/j.clgc.2017.06.004. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28729067

8

Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting.

Oh WK, Miao R, Vekeman F, Sung J, Cheng WY, Gauthier-Loiselle M, Dhawan R, Duh MS. Oh WK, et al. Among authors: cheng wy. Med Oncol. 2017 Aug 10;34(9):160. doi: 10.1007/s12032-017-1014-2. Med Oncol. 2017. PMID: 28795333 Free PMC article.

9

Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia.

Jabbour E, DerSarkissian M, Duh MS, McCormick N, Cheng WY, McGarry LJ, Souroutzidis A, Huang H, O'Brien S, Ravandi F, Kantarjian HM. Jabbour E, et al. Among authors: cheng wy. Clin Lymphoma Myeloma Leuk. 2018 Apr;18(4):257-265. doi: 10.1016/j.clml.2018.02.010. Epub 2018 Feb 17. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29519619

10

Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets.

Cheng WY, Said Q, Hao Y, Xiao Y, Vekeman F, Bobbili P, Duh MS, Nandal S, Blinder M. Cheng WY, et al. Curr Med Res Opin. 2018 Nov;34(11):1959-1966. doi: 10.1080/03007995.2018.1470500. Epub 2018 Jun 4. Curr Med Res Opin. 2018. PMID: 29701080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters